Interim Management Statement (9710L)
09 8월 2011 - 3:00PM
UK Regulatory
TIDMOXIG
RNS Number : 9710L
Oxford Instruments PLC
09 August 2011
Oxford Instruments plc
Interim Management Statement
For release 9 August 2011
Oxford Instruments plc, a leading provider of high technology
tools and systems for industry and research, today issues an
Interim Management Statement which covers the period from 1 April
2011 to date.
As anticipated, orders, sales and profits for the Group are all
ahead of the same period in the prior year.
Our Research markets remain robust and orders within our
Industrial markets are continuing at the strong levels seen in the
second half of last year. The Service division continues to perform
well across all our aftermarket revenue streams.
On 14 June, the Group announced the acquisitions of Omicron
Nanotechnology GmbH and Omniprobe Inc. for a combined consideration
of GBP40 million, and an associated equity placing of GBP38
million. We also announced our 14 cubed strategy; to target
compound revenue growth of 14% and a Trading Profit return on sales
of 14%, by 2014. The integration of the acquisitions and the
implementation of the strategy are progressing as planned.
Save as described in this statement, there has been no
significant change in the financial position of the Group in the
period.
The Group has made an encouraging start to the year. The
diversity of our activities, both by served markets and by
geography, combined with our strong pipeline of new products, will
continue to provide growth opportunities for the Group.
Accordingly, the Board anticipates that Oxford Instruments will
continue to make good progress in line with its expectations for
the financial year.
Enquiries:
Oxford Instruments plc Tel: 01865 393200
Jonathan Flint, Chief Executive
Kevin Boyd, Group Finance Director
MHP Tel: 020 3128 8100
Rachel Hirst / Ian Payne
This Interim Management Statement contains certain
forward-looking statements which have been made by the Directors in
good faith using information available up until the date they
approved the Statement. Forward-looking statements should be
regarded with caution as by their nature such statements involve
risk and uncertainties relating to events and circumstances that
may occur in the future. Actual results may differ from those
expressed in such statements, depending on the outcome of these
uncertain future events.
Notes to Editors
Oxford Instruments designs, supplies and supports
high-technology tools and systems with a focus on research and
industrial applications. It provides solutions needed to advance
fundamental physics research and its transfer into commercial
nanotechnology applications. Innovation has been the driving force
behind Oxford Instruments' growth and success for over 50 years,
and its strategy is to effect the successful commercialisation of
these ideas by bringing them to market in a timely and
customer-focused fashion.
The first technology business to be spun out from Oxford
University over fifty years ago, Oxford Instruments is now a global
company with over 1700 staff worldwide and a listing on the London
Stock Exchange (OXIG). Its objective is to be the leading provider
of new generation tools and systems for the research and industrial
sectors.
This involves the combination of core technologies in areas such
as low temperature and high magnetic field environments, Nuclear
Magnetic Resonance, X-ray electron and optical based metrology, and
advanced growth, deposition and etching. Oxford Instruments'
products, expertise, and ideas address global issues such as
energy, environment, security and health.
This information is provided by RNS
The company news service from the London Stock Exchange
END
IMSBUGDISSGBGBI
Oxford Instruments (LSE:OXIG)
과거 데이터 주식 차트
부터 9월(9) 2024 으로 10월(10) 2024
Oxford Instruments (LSE:OXIG)
과거 데이터 주식 차트
부터 10월(10) 2023 으로 10월(10) 2024